Anna Bobčáková

549 total citations
15 papers, 221 citations indexed

About

Anna Bobčáková is a scholar working on Infectious Diseases, Molecular Biology and Neurology. According to data from OpenAlex, Anna Bobčáková has authored 15 papers receiving a total of 221 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 5 papers in Molecular Biology and 5 papers in Neurology. Recurrent topics in Anna Bobčáková's work include COVID-19 Clinical Research Studies (6 papers), Long-Term Effects of COVID-19 (5 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). Anna Bobčáková is often cited by papers focused on COVID-19 Clinical Research Studies (6 papers), Long-Term Effects of COVID-19 (5 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). Anna Bobčáková collaborates with scholars based in Slovakia, Sweden and Belgium. Anna Bobčáková's co-authors include Miloš Jeseňák, Peter Bánovčin, Zuzana Rennerová, Ingrid Urbančíková, Zuzana Diamant, Zuzana Daňková, Erika Halášová, Eva Baranovičová, Vladimír Nosáľ and Ján Lehotský and has published in prestigious journals such as SHILAP Revista de lepidopterología, CHEST Journal and Frontiers in Immunology.

In The Last Decade

Anna Bobčáková

13 papers receiving 221 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Bobčáková Slovakia 8 147 89 42 32 27 15 221
Nancy Grisel United States 5 198 1.3× 110 1.2× 45 1.1× 29 0.9× 38 1.4× 7 269
Marie Koubi France 6 156 1.1× 88 1.0× 50 1.2× 29 0.9× 21 0.8× 9 220
Stefania Notari Italy 8 107 0.7× 44 0.5× 35 0.8× 43 1.3× 16 0.6× 18 192
Quan Cao China 4 204 1.4× 137 1.5× 43 1.0× 14 0.4× 19 0.7× 7 264
Mahmoud Saad Egypt 6 67 0.5× 97 1.1× 19 0.5× 43 1.3× 13 0.5× 17 190
Jianglin Xiang China 2 255 1.7× 149 1.7× 24 0.6× 16 0.5× 23 0.9× 5 308
Oksana V. Stanevich Russia 10 182 1.2× 87 1.0× 46 1.1× 25 0.8× 12 0.4× 21 220
Bangshuo Zhang China 3 202 1.4× 137 1.5× 30 0.7× 18 0.6× 14 0.5× 4 269
Mohamed Aboukamar Qatar 5 216 1.5× 133 1.5× 16 0.4× 12 0.4× 20 0.7× 11 276

Countries citing papers authored by Anna Bobčáková

Since Specialization
Citations

This map shows the geographic impact of Anna Bobčáková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Bobčáková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Bobčáková more than expected).

Fields of papers citing papers by Anna Bobčáková

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Bobčáková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Bobčáková. The network helps show where Anna Bobčáková may publish in the future.

Co-authorship network of co-authors of Anna Bobčáková

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Bobčáková. A scholar is included among the top collaborators of Anna Bobčáková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Bobčáková. Anna Bobčáková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Bobčáková, Anna, et al.. (2025). Is Canakinumab Safe During Pregnancy? New Insights from Three Cases in Slovakia. SHILAP Revista de lepidopterología. 5(2). 12–12. 1 indexed citations
2.
Jeseňák, Miloš, et al.. (2025). Unexpectedly high prevalence of familial Mediterranean fever in Slovakia. Clinical and Experimental Medicine. 25(1). 101–101.
3.
Jeseňák, Miloš, Anna Bobčáková, Korneliusz Golebski, et al.. (2025). Airway epithelial barrier integrity: an emerging treatable trait in asthma management. Respiratory Medicine. 252. 108579–108579.
4.
Samec, Marek, Anna Bobčáková, Eva Baranovičová, et al.. (2025). Comparative Study of Cytokine Profiles in SARS-CoV-2 Delta and Omicron Variants. Bratislavské lekárske listy/Bratislava medical journal. 126(3). 286–298. 3 indexed citations
5.
Bobčáková, Anna, et al.. (2024). Association Between Cytometric Biomarkers, Clinical Phenotype, and Complications of Common Variable Immunodeficiency. Cureus. 16(1). e52941–e52941. 1 indexed citations
6.
Jeseňák, Miloš, Anna Bobčáková, Ratko Djukanović, et al.. (2024). Promoting Prevention and Targeting Remission of Asthma. CHEST Journal. 167(4). 956–974. 7 indexed citations
7.
Lipták, Péter, Eva Baranovičová, Anna Bobčáková, et al.. (2023). Changes in the Urine Metabolomic Profile in Patients Recovering from Severe COVID-19. Metabolites. 13(3). 364–364. 4 indexed citations
8.
Bobčáková, Anna, et al.. (2023). The use of ketotifen as long-term anti-inflammatory prophylaxis in children with PFAPA syndrome. Frontiers in Immunology. 14. 1302875–1302875. 5 indexed citations
9.
Bobčáková, Anna, et al.. (2022). Activated CD8+CD38+ Cells Are Associated With Worse Clinical Outcome in Hospitalized COVID-19 Patients. Frontiers in Immunology. 13. 861666–861666. 7 indexed citations
10.
Lipták, Péter, Eva Baranovičová, Anna Bobčáková, et al.. (2022). Persistence of Metabolomic Changes in Patients during Post-COVID Phase: A Prospective, Observational Study. Metabolites. 12(7). 641–641. 16 indexed citations
11.
Bobčáková, Anna, et al.. (2021). Immune Profile in Patients With COVID-19: Lymphocytes Exhaustion Markers in Relationship to Clinical Outcome. Frontiers in Cellular and Infection Microbiology. 11. 646688–646688. 51 indexed citations
12.
Bobčáková, Anna, et al.. (2021). Inhibitory Immune Checkpoint Molecules and Exhaustion of T cells in COVID-19. Physiological Research. 70(S2). S227–S247. 18 indexed citations
13.
Baranovičová, Eva, Anna Bobčáková, Zuzana Daňková, et al.. (2021). The Ability to Normalise Energy Metabolism in Advanced COVID-19 Disease Seems to Be One of the Key Factors Determining the Disease Progression—A Metabolomic NMR Study on Blood Plasma. Applied Sciences. 11(9). 4231–4231. 19 indexed citations
14.
Antošová, Martina, et al.. (2021). COVID-19 and the Differences in Physiological Background Between Children and Adults and Their Clinical Consequences. Physiological Research. 70(S2). S209–S225. 11 indexed citations
15.
Jeseňák, Miloš, et al.. (2020). Immune Parameters and COVID-19 Infection – Associations With Clinical Severity and Disease Prognosis. Frontiers in Cellular and Infection Microbiology. 10. 364–364. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nancy Grisel Breakdown of academic impact, for papers by Marie Koubi Breakdown of academic impact, for papers by Stefania Notari Breakdown of academic impact, for papers by Quan Cao Breakdown of academic impact, for papers by Mahmoud Saad Breakdown of academic impact, for papers by Jianglin Xiang Breakdown of academic impact, for papers by Oksana V. Stanevich Breakdown of academic impact, for papers by Bangshuo Zhang Breakdown of academic impact, for papers by Mohamed Aboukamar
Rankless by CCL
2026